The Ankylosing Spondylitis Market: Robust Growth Driven by Innovation and Expanding Treatment Options
The global ankylosing spondylitis (AS) market is experiencing unprecedented growth, emerging as one of the most dynamic segments in the autoimmune disease therapeutics landscape. This chronic inflammatory condition, primarily affecting the spine and sacroiliac joints, has garnered significant attention from pharmaceutical companies, healthcare providers, and investors alike. Request a Sample: https://www.futurewiseresearch.com/contact.aspx?rpt=8996&type=requestsample Market Size and Growth Trajectory The ankylosing spondylitis market size in the 7MM was USD 5.1 billion in 2024 and will reach USD 10.2 Billion by 2035 at a CAGR of 6.53% during 2025-2035. This robust growth trajectory reflects the increasing recognition of AS as a serious medical condition requiring specialized treatment approaches. Various market research firms project slightly different figures, with some estimates suggesting even higher growth rates. The market size was valued at USD 6.88 Billion in 2...